Category Archives: TB

Survey shows Xpert TB diagnosis costly, out of reach in countries where private care predominates

By on .

Patients in the highest tuberculosis-burden countries who primarily rely on the private sector for their healthcare needs do not have access to the GeneXpert MTB/RIF diagnostic test for drug-resistant tuberculosis, according to a new study published in The Lancet. And if they do have access, the people who most need the test can’t afford it. Researchers […]

USAID announces new partnerships to combat MDR-TB at White House plan launch

By on .

At last week’s launch of the National Action Plan for Combating Multidrug-Resistant Tuberculosis, the U.S. Agency for International Development announced expanded partnerships with Janssen, the maker of bedaquiline, the first tuberculosis drug to be produced since the 1950s, and Cepheid, maker of the GeneXpert rapid diagnostic test for drug-resistant tuberculosis. Janssen, the pharmaceutical branch of […]

MDR-TB national action plan raises questions on targets and funding

By on .

After waiting months for the White House’s release of the National Action Plan for Combating Multidrug-Resistant Tuberculosis, TB advocates are asking why the plan isn’t more ambitious (considering some of the plan’s milestones are already close to being reached), and whether the Obama Administration will propose enough funding to put the plan into action. The alternative, they […]

White House releases plan to combat MDR-TB at home and around the world

By on .

With the acknowledgement that tuberculosis that is not effectively confronted anywhere poses threats to public health both globally and domestically, the White House today released a plan setting specific treatment and disease impact targets in the U.S. and abroad as well as goals to build collaborative international responses and capacities to fight the disease. The […]

WHO’s new TB research framework to help high burden countries take leadership

By on .

To develop tools to meet the goals set out in the World Health Organization End TB strategy, which includes reducing tuberculosis incidence by 80 percent and deaths by 90 percent by 2035, last week the WHO announced the launch of a global action framework for tuberculosis research. The framework outlines steps at global and national […]

TB diagnostic offers hope, while disease detection in highest burden country lags

By on .

Imagine if patients with suspected tuberculosis, possibly drug resistant, could be diagnosed, no matter where they live, immediately and reliably at their local health centers — even if their local health centers had unreliable electricity, and no laboratory. It would be possible with a light-weight, portable wireless device that can be attached to a smartphone. The machine […]

Following release of WHO TB report, a discussion examines how to end an epidemic

By on .

“For some reason, diseases usually start equally among everyone in society, but every disease always falls down to the poorest of the poor,” Larry Gostin said Wednesday. “Now we see that tuberculosis has fallen down to the poorest of the poor,” Gostin, O’Neill Institute Chair of Georgetown University and director of the World Health Organization […]

WHO report shows TB, treatable and curable, surpassing HIV as No. 1 infectious disease killer

By on .

While tuberculosis deaths have dropped by nearly half since 1990, an estimated 4400 people die daily from TB, a disease “that often strikes the voiceless . . .” As World Health Organization report is released, USAID official says White House “is close to” releasing plan for multidrug-resistant tuberculosis . . . With the deaths of […]

Lancet TB series on local data, active case-finding, preventive treatment, community input and more . . . We’re reading how to end tuberculosis

By on .

A Lancet special series developed by an international team and led by Dr. Salmaan Keshavjee of Harvard Medical School’s Department of Global Health and Social Medicine lays out proven elements of tuberculosis control and how they can be worked into comprehensive approaches in high-risk, low-resource settings. And, at the same time the latest antiretroviral treatment […]